Bebaas, Inc.

A pivotal clinical trial with our Cobacan™ will allow us to gain FDA approval for the only patented viable replacement for painful vitamin B12 injections.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Carlsbad, CA, US
  • Currency USD
  • Founded 2004
  • Employees 3
  • Website bebaas.com

Company Summary

Bebaas, Inc. is a small biotech company that has a patented, orally absorbed combination of three vitamin B12 isoforms that will make painful weekly injections in patients with clinical B12 deficiency unnecessary. Preclinical PK studies are promising and we are ready to manufacture the lozenges and to conduct a pivotal clinical trial. We expect to be able to submit to the FDA in 12 months

Team

  • Bork Balkan
    COO

    B. Balkan has a Ph.D. in physiology and has worked for 23 years in the pharmaceutical and biotech industry. He has brought of projects from inception through discovery and into development in both large and small organisations. He has authored more than 30 peer-reviewed scientific articles and book chapters.

  • Chad Brown
    President and CEO

    Mr. Brown is the inventor of the IP behind Cobacan™ and the Company’s
    research platform. Chad Brown has a background in financials. He has been involved in biotech companies for over ten years. He was COO for Biogentech and is currently Chairman of the board for Bebaas, Inc., Snapcapz, Inc., and Liquid Biosciences.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free